Claims for Patent: 7,429,387
✉ Email this page to a colleague
Summary for Patent: 7,429,387
| Title: | Use of botulinum toxin therapy for treatment of recalcitrant voiding dysfunction |
| Abstract: | The present invention related to methods for treating neurological-urological conditions. This is accomplished by administration of at least one neurotoxin. |
| Inventor(s): | Schmidt; Richard A. (Arvada, CO) |
| Assignee: | The Regents of the University of Colorado (Boulder, CO) |
| Application Number: | 11/077,895 |
| Patent Claims: | 1. A method for treating a recalcitrant voiding dysfunction, the method comprising the step of injecting a botulinum toxin to a lateral bladder wall of a patient, thereby
treating the recalcitrant voiding dysfunction.
2. The method of claim 1, wherein the patent is a human. 3. The method of claim 1, wherein the patient is a human female. 4. The method of claim 1, wherein the patient is a human male. 5. The method of claim 1, wherein the botulinum toxin is a botulinum toxin type A. 6. The method of claim 1, wherein a symptom of the recalcitrant voiding dysfunction is urinary incontinence. 7. A method for treating a recalcitrant voiding dysfunction, the method comprising the step of injecting a therapeutically effective amount of a botulinum toxin type A to a lateral bladder wall a patient, thereby treating the recalcitrant voiding dysfunction. 8. The method of claim 7, wherein the botulinum toxin type A is injected in the amount up to 2500 units. 9. The method of claim 7, wherein the therapeutically effective amount of botulinum toxin type A is about 1.4 IU/kg to 17.1 IU/kg of botulinum toxin type A. 10. The method of claim 7, wherein the therapeutically effective amount of botulinum toxin type A is 200 IU of botulinum toxin type A. 11. The method of claim 7, wherein the therapeutically effective amount of botulinum toxin type A is 400 IU of botulinum toxin type A. |
Details for Patent 7,429,387
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Abbvie Inc. | BOTOX COSMETIC | onabotulinumtoxina | For Injection | 103000 | December 09, 1991 | ⤷ Try for Free | 2017-07-15 |
| Abbvie Inc. | BOTOX | onabotulinumtoxina | For Injection | 103000 | December 09, 1991 | ⤷ Try for Free | 2017-07-15 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
Showing 1 to 2 of 2 entries
International Patent Family for US Patent 7,429,387
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Australia | 2005234633 | ⤷ Try for Free |
| Australia | 743085 | ⤷ Try for Free |
| Austria | E314085 | ⤷ Try for Free |
| Austria | E320815 | ⤷ Try for Free |
| Austria | E339220 | ⤷ Try for Free |
| Austria | E448792 | ⤷ Try for Free |
| Austria | E552006 | ⤷ Try for Free |
| >Country | >Patent Number | >Estimated Expiration |
Showing 1 to 7 of 7 entries
